1 Product identity
Ingredient risk
1 ingredient to use with caution
Chitosan 500 mg
BrandNova Nutritions→Fiber and Other Nutrients Tablet or Pill 11 ingredients 1 caution DSLD #229286Net contents: 120 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2020-06-24
2 Ingredients (11)
IngredientGroupSafety
Total CarbohydratesCarbohydrate—
Dietary FiberFiber (unspecified)—
ChitosanChitosan—
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Phosphorus — Generally Safe
⚠ Excess impairs calcium absorption
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID229286
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2020-06-24
6 More from Nova Nutritions
View Nova Nutritions Safety Scorecard → 12 products
5-HTP 100 mg5-HTP 200 mgApple PectinBiotin 10,000 mcgBlack SeedChromium Picolinate 1000 mcg7 Cite this page
Vancouver
Pkhakadze G. Chitosan 500 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 19]. Available from: https://supplement.ge/products/dsld-229286/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG